Last reviewed 2026-04-19 · How we verify

Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease

83 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease patent landscape — cliff calendar, originator estates, attackable patents
Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease treatment landscape brief
Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease treatment updates RSS

Frequently asked questions about Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease

What drugs treat Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease?

Tracked treatments include Tafamidis (Reference).

What is the treatment for Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease?

Standard treatment for Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease includes Tafamidis (Reference). See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease patent cliff · Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease CI report
Treatment: Tafamidis (Reference) · Pfizer
Treatment: Tafamidis (Reference) · Pfizer
Treatment: Tafamidis (Reference) · Pfizer
Treatment: Tafamidis (Reference) · Pfizer
Treatment: Tafamidis (Reference) · Pfizer
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing